Академический Документы
Профессиональный Документы
Культура Документы
Special Considerations for Adolescents and Young Adults With Hematologic Malignancies
Suzanne Ameringer, PhD, RN
Assistant Professor Family and Community Health Nursing Virginia Commonwealth University Richmond, Virginia
This program is supported by educational grants from
Faculty
Program Chair
Jeanne M. Erickson, PhD, RN, AOCN
Assistant Professor University of Virginia School of Nursing Charlottesville, Virginia
Faculty Disclosures
Jeanne M. Erickson, PhD, RN, AOCN, has no significant financial relationships to disclose.
Suzanne Ameringer, PhD, RN, has no significant financial relationships to disclose.
Psychosocial Issues
Adherence
Quality of life Survivorship
Adherence in AYAs
Rates of adherence
Nonadherence highest among adolescents compared with younger and older patients 27% of adolescents had no trimethoprim/sulfamethoxazole in blood at 6 mos after diagnosis[1]
Poor adherence may be one of the reasons for poorer outcomes in AYAs
Self-esteem
Depressive symptoms Need for independence
Adherence Interventions
Provider approaches[1]
Information on all new meds and dosage changes Simplify med schedule and align with AYAs daily routine
AYA intervention
Video game of cancer treatment and care issues improved treatment adherence in AYAs (13-29 yrs)[2]
1. NCCN. Clinical practice guidelines in oncology: adolescent and young adult oncology. v.1.2012. 2. Kato PM, et al. Pediatrics. 2008;122:e305-e317.
Quality of Life
Stunning loss of normalcy[1]
Health-related quality of life low at diagnosis, then increases over time[2] Adverse effects of treatment on physical and psychosocial function
1. Stegenga K, et al. J Pediatr Oncol Nurs 2009;26:75-80. 2. Jrngrden A, at al. Eur J Cancer. 2007;43:1952-1958.
Disability
Sexuality Potential loss of reproductivity
NCCN. Clinical practice guidelines in oncology: adolescent and young adult oncology. v.1.2012
Stupidcancer.org
Survivorship
Lack adequate follow-up and long-term care
Survival trends are lowest compared with younger and older patients[1]
1. Bleyer A, et al. Cancer epidemiology in older adolescents and young adults 15 to 29 years of age, including SEER incidence and survival: 1975-2000. NCI NIH Pub. No. 06-5767; 2006.
Disability
Mental health Relationships
Fear
Positive effects
1. Nightingale CL, et al. J Adol Young Adult Oncol. 2011;1:124-132. 2. NCCN. Clinical practice guidelines in oncology: adolescent and young adult oncology. v.1.2012.
Pulmonary complications
Lung fibrosis and pleurisy from lung radiation and chemotherapy
Neurological complications
Cranial radiation: risk for negative cognitive effects and lower physical function Adolescents at greater risk for radiation-induced spinal cord dysfunction
1. NCCN. Clinical practice guidelines in oncology: adolescent and young adult oncology. v.1.2012.
Survivorship Interventions
Transition programs
Survivorship plan
Address financial issues in survivor plan
Conclusions
Nonadherence
Need to know outcomes of nonadherence NOT only chemotherapy
Quality of life
More attention to sexuality, loss of reproductivity, mental health
Survivorship
Adequate long-term care Higher risk for cardiovascular complications Develop and continually reassess survivorship plan
clinicaloptions.com/oncology